News Conference News ACC 2022 Bentracimab Swiftly Reverses Ticagrelor, Platelet-Function Study Affirms Todd Neale April 02, 2022
News Conference News ACC 2021 Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM L.A. McKeown May 16, 2021
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
Presentation ACC 2020 EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020
News Conference News ACC 2020 Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes Yael L. Maxwell March 30, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Conference News ACC 2019 First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results Yael L. Maxwell March 25, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Conference News ACC 2014 CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit April 02, 2014
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013